Literature DB >> 30031492

Juvenile Idiopathic Arthritis: Oligoarthritis and Polyarthritis.

Courtney B Crayne1, Timothy Beukelman2.   

Abstract

Juvenile idiopathic arthritis (JIA) comprises a group of heterogeneous diseases further divided into various categories based on shared clinical presentation, laboratory markers, and disease prognosis. Extra-articular complications include uveitis and growth abnormalities. Disease course and prognosis vary with respect to each JIA category and subsequently guide respective treatment. Over the past few decades, considerable treatment advances have significantly reduced the morbidity associated with childhood arthritis. Nevertheless, the treatments are not curative; many children continue to have active disease into adulthood. Emphasis is placed on the initiation of early aggressive therapy in hopes of delaying disease progression and inducing remission.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Classification; Diagnosis; Juvenile idiopathic arthritis; Oligoarthritis; Polyarthritis; Treatment

Mesh:

Substances:

Year:  2018        PMID: 30031492     DOI: 10.1016/j.pcl.2018.03.005

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  8 in total

1.  A Study Protocol for the Management of Children With Juvenile Idiopathic Arthritis Based on ePROs.

Authors:  Biyu Shen; Songsong Shi; Hengmei Cui; Yunyun Li; Haoyang Chen; Huan Jin; Jia Xu; Zuojia Liu; Yanliang Jin
Journal:  Front Pediatr       Date:  2022-07-06       Impact factor: 3.569

2.  Increased Relapse Rate During COVID-19 Lockdown in an Italian Cohort of Children With Juvenile Idiopathic Arthritis.

Authors:  Roberta Naddei; Renata Alfani; Martina Bove; Valentina Discepolo; Filomena Mozzillo; Alfredo Guarino; Maria Alessio
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-08-16       Impact factor: 5.178

Review 3.  Targeting Tregs in Juvenile Idiopathic Arthritis and Juvenile Dermatomyositis-Insights From Other Diseases.

Authors:  Romy E Hoeppli; Anne M Pesenacker
Journal:  Front Immunol       Date:  2019-01-25       Impact factor: 7.561

4.  Capillary microscopy is a potential screening method for connective tissue disease in children with Raynaud's phenomenon.

Authors:  Claudette A Farenhorst; Anniek M Roon; Anne I Gessel; Alja J Stel; Hendrika Bootsma; Wineke Armbrust; Douwe J Mulder
Journal:  Pediatr Rheumatol Online J       Date:  2022-02-08       Impact factor: 3.054

5.  Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trial.

Authors:  Liuting Zeng; Tiejun Yang; Kailin Yang; Ganpeng Yu; Jun Li; Wang Xiang; Hua Chen
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

6.  Plasma Glycosaminoglycans in Children with Juvenile Idiopathic Arthritis Being Treated with Etanercept as Potential Biomarkers of Joint Dysfunction.

Authors:  Magdalena Wojdas; Klaudia Dąbkowska; Kornelia Kuźnik-Trocha; Grzegorz Wisowski; Iwona Lachór-Motyka; Katarzyna Komosińska-Vassev; Krystyna Olczyk; Katarzyna Winsz-Szczotka
Journal:  Biomedicines       Date:  2022-07-31

7.  Capturing critical data elements in Juvenile Idiopathic Arthritis: initiatives to improve data capture.

Authors:  Meghan E Ryan; Andrew Warmin; Bryce A Binstadt; Colleen K Correll; Emily Hause; Patricia Hobday; Alison Lerman; Shawn A Mahmud; Mona M Riskalla; Zachary Shaheen; Richard K Vehe; Danielle R Bullock
Journal:  Pediatr Rheumatol Online J       Date:  2022-09-29       Impact factor: 3.413

8.  Foot and Ankle Conventional Radiography in Juvenile Idiopathic Arthritis: Does It Still Matter?

Authors:  Magdalena Posadzy; Anna Sowińska; Filip Vanhoenacker; Piotr Gietka; Ewa Żelnio; Iwona Sudoł-Szopińska
Journal:  J Belg Soc Radiol       Date:  2022-09-23       Impact factor: 1.912

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.